Skip to Content
MilliporeSigma
All Photos(1)

Documents

Y0000136

Enilconazole

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

Imazalil, 1-[2-(Allyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C14H14Cl2N2O
CAS Number:
Molecular Weight:
297.18
Beilstein/REAXYS Number:
545683
MDL number:
UNSPSC Code:
41116107
PubChem Substance ID:
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

enilconazole

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

SMILES string

Clc1ccc(C(Cn2ccnc2)OCC=C)c(Cl)c1

InChI

1S/C14H14Cl2N2O/c1-2-7-19-14(9-18-6-5-17-10-18)12-4-3-11(15)8-13(12)16/h2-6,8,10,14H,1,7,9H2

InChI key

PZBPKYOVPCNPJY-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

Enilconazole is a topically active imidazole derivative, for veterinary application in poultry against Aspergillus sp., and in dogs, cattle, and horses for the treatment of dermatophytosis.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Enilconazole may be used as a reference compound to analyze the effect of enilconazole during the surgical treatment of canine nasal aspergillosis by rhinotomy combined with enilconazole infusion and oral itraconazole.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

related product

signalword

Danger

Hazard Classifications

Acute Tox. 3 Oral - Acute Tox. 4 Inhalation - Aquatic Chronic 1 - Carc. 2 - Eye Dam. 1

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Treatment of canine nasal aspergillosis with enilconazole.
Sharp N J, et al.
Journal of Veterinary Internal Medicine, 7(1), 40-43 (1993)
Surgical treatment of canine nasal aspergillosis by rhinotomy combined with enilconazole infusion and oral itraconazole.
Claeys S, et al.
The Journal of Small Animal Practice, 47(6), 320-324 (2006)
Liwei An et al.
Antiviral research, 109, 54-63 (2014-06-28)
Infection with influenza A virus is still a global concern since it causes significant mortality, morbidity and economic loss. New burst pandemics and rapid emergence of drug-resistance strains in recent years call for novel antiviral therapies. One promising way to
Vera van Noort et al.
Cancer research, 74(20), 5690-5699 (2014-07-20)
Drug-induced gene-expression profiles that invert disease profiles have recently been illustrated to be a starting point for drug repositioning. In this study, we validate this approach and focus on prediction of novel drugs for colorectal cancer, for which there is

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service